- Exchange: Shanghai
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Harbin Pharmaceutical Group Co Ltd
+ Add to Watchlist600664:CH
7.690 CNY 0.070 0.92%As of 01:19:17 ET on 05/21/2013.
Snapshot for Harbin Pharmaceutical Group Co Ltd (600664)
| Open: | 7.600 | Day's Range: | 7.480 - 7.730 | Volume: | 14,190,394 |
|---|---|---|---|---|---|
| Previous Close: | 7.620 | 52wk Range: | 5.400 - 7.870 | 1-Yr Rtn: | +11.29% |
Key Statistics for 600664
| Current P/E Ratio (ttm) | 19.2735 |
|---|---|
| Estimated P/E(12/2013) | 20.6486 |
| Relative P/E vs. SHASHR | 1.5707 |
| Earnings Per Share (CNY) (ttm) | 0.3964 |
| Est. EPS (CNY) (12/2013) | 0.3700 |
| Est. PEG Ratio | - |
| Market Cap (M CNY) | 14,649.57 |
| Shares Outstanding (M) | 1,917.48 |
| 30 Day Average Volume | 17,026,510 |
| Price/Book (mrq) | 1.8005 |
| Price/Sale (ttm) | 0.8305 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (CNY) | - |
| Last Dividend | 08/01/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 600664
Company Profile & Key Executives for 600664
Harbin Pharmaceutical Group Co., Ltd. develops and manufactures a variety of medicines, preparations, Chinese traditional medicines, healthcare products, and biopharmaceuticals. The Company's main products include penicillin, calcium gluconate, etc.
| Zhang LijunChairman/President | Wu ZhijunVice President |
| Meng XiaodongVP/Secretary | Liu BoChief Accountant |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
600664 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page